Legislation
National Drug Authority Approves Lenacapavir for HIV Prevention in Uganda
Uganda·National Drug Authority Uganda··⏱️ 1 min readWire Summary
National Drug Authority has just approved Lenacapavir, a twice-yearly dose PrEP manufactured by Gilead, a USA based company. This is a game-changer for HIV prevention, especially for those at high risk. This is great step towards ending AIDS by 2030
AI Business Impact
How does this affect your business?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
Wansom is AI and can make mistakes.